-
1
-
-
33745246339
-
Clinical practice guidelines for vascular access
-
Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S176-S247, 2006
-
(2006)
Am J Kidney Dis
, vol.48
, Issue.SUPPL. 1
-
-
-
2
-
-
1542426359
-
Medical factors affecting patency of arteriovenous access
-
Abularrage CJ, Sidawy AN, Weiswasser JM, White PW, Arora S: Medical factors affecting patency of arteriovenous access. Semin Vasc Surg 17: 25-31, 2004
-
(2004)
Semin Vasc Surg
, vol.17
, pp. 25-31
-
-
Abularrage, C.J.1
Sidawy, A.N.2
Weiswasser, J.M.3
White, P.W.4
Arora, S.5
-
3
-
-
0042932664
-
Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients
-
Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M: Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int 64: 1101-1107, 2003
-
(2003)
Kidney Int
, vol.64
, pp. 1101-1107
-
-
Heine, G.H.1
Ulrich, C.2
Sester, U.3
Sester, M.4
Kohler, H.5
Girndt, M.6
-
4
-
-
0037373888
-
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients
-
Fukasawa M, Matsushita K, Kamiyama M, Mikami Y, Araki I, Yamagata Z, Takeda M: The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 41: 637-642, 2003
-
(2003)
Am J Kidney Dis
, vol.41
, pp. 637-642
-
-
Fukasawa, M.1
Matsushita, K.2
Kamiyama, M.3
Mikami, Y.4
Araki, I.5
Yamagata, Z.6
Takeda, M.7
-
5
-
-
30944442094
-
Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients
-
Lin CC, Yang WC, Lin SJ, Chen TW, Lee WS, Chang CF, Lee PC, Lee SD, Su TS, Fann CS, Chung MY: Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69: 165-172, 2006
-
(2006)
Kidney Int
, vol.69
, pp. 165-172
-
-
Lin, C.C.1
Yang, W.C.2
Lin, S.J.3
Chen, T.W.4
Lee, W.S.5
Chang, C.F.6
Lee, P.C.7
Lee, S.D.8
Su, T.S.9
Fann, C.S.10
Chung, M.Y.11
-
6
-
-
0026548912
-
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
-
Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
-
(1992)
Lancet
, vol.339
, pp. 572-575
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
7
-
-
0242322346
-
Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: its role in hypercholesterolemia
-
Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chang JR, Tangphao O, Blaschke TF, Cooke JP: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98: 1842-1847, 1998
-
(1998)
Circulation
, vol.98
, pp. 1842-1847
-
-
Boger, R.H.1
Bode-Boger, S.M.2
Szuba, A.3
Tsao, P.S.4
Chang, J.R.5
Tangphao, O.6
Blaschke, T.F.7
Cooke, J.P.8
-
8
-
-
38349019064
-
Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits? A systematic review
-
Jacobi J, Tsao PS: Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits? A systematic review. Am J Nephrol 28: 224-237, 2007
-
(2007)
Am J Nephrol
, vol.28
, pp. 224-237
-
-
Jacobi, J.1
Tsao, P.S.2
-
9
-
-
0035936406
-
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
-
Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
-
(2001)
Lancet
, vol.358
, pp. 2113-2117
-
-
Zoccali, C.1
Bode-Boger, S.2
Mallamaci, F.3
Benedetto, F.4
Tripepi, G.5
Malatino, L.6
Cataliotti, A.7
Bellanuova, I.8
Fermo, I.9
Frolich, J.10
Boger, R.11
-
10
-
-
0026484859
-
Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
-
Beathard GA: Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 42: 1390-1397, 1992
-
(1992)
Kidney Int
, vol.42
, pp. 1390-1397
-
-
Beathard, G.A.1
-
11
-
-
0023463094
-
The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas
-
Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS: The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg 206: 777-781, 1987
-
(1987)
Ann Surg
, vol.206
, pp. 777-781
-
-
Glanz, S.1
Gordon, D.H.2
Butt, K.M.3
Hong, J.4
Lipkowitz, G.S.5
-
13
-
-
0032502337
-
Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
-
Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 97: 916-931, 1998
-
(1998)
Circulation
, vol.97
, pp. 916-931
-
-
Motwani, J.G.1
Topol, E.J.2
-
14
-
-
33645468474
-
Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint
-
Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127, 2006
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1112-1127
-
-
Roy-Chaudhury, P.1
Sukhatme, V.P.2
Cheung, A.K.3
-
15
-
-
0036149851
-
Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas
-
Clark TW, Hirsch DA, Jindal KJ, Veugelers PJ, LeBlanc J: Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol 13: 51-59, 2002
-
(2002)
J Vasc Interv Radiol
, vol.13
, pp. 51-59
-
-
Clark, T.W.1
Hirsch, D.A.2
Jindal, K.J.3
Veugelers, P.J.4
LeBlanc, J.5
-
16
-
-
3242750470
-
Dysfunctional autogenous hemodialysis fistulas: Outcomes after angioplasty: Are there clinical predictors of patency?
-
Rajan DK, Bunston S, Misra S, Pinto R, Lok CE: Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty: Are there clinical predictors of patency? Radiology 232: 508-515, 2004
-
(2004)
Radiology
, vol.232
, pp. 508-515
-
-
Rajan, D.K.1
Bunston, S.2
Misra, S.3
Pinto, R.4
Lok, C.E.5
-
17
-
-
1942438521
-
Asymmetrical dimethylarginine: The Uber marker?
-
Cooke JP: Asymmetrical dimethylarginine: The Uber marker? Circulation 109: 1813-1818, 2004
-
(2004)
Circulation
, vol.109
, pp. 1813-1818
-
-
Cooke, J.P.1
-
18
-
-
0032893051
-
Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia
-
Masuda H, Goto M, Tamaoki S, Azuma H: Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol 126: 211-218, 1999
-
(1999)
Br J Pharmacol
, vol.126
, pp. 211-218
-
-
Masuda, H.1
Goto, M.2
Tamaoki, S.3
Azuma, H.4
-
19
-
-
0033667562
-
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
-
Boger RH, Bode-Boger SM, Tsao PS, Lin PS, Chan JR, Cooke JP: An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36: 2287-2295, 2000
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 2287-2295
-
-
Boger, R.H.1
Bode-Boger, S.M.2
Tsao, P.S.3
Lin, P.S.4
Chan, J.R.5
Cooke, J.P.6
-
20
-
-
1642453719
-
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans
-
Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC, Hoeper MM, Haller H, Fliser D: Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109: 172-177, 2004
-
(2004)
Circulation
, vol.109
, pp. 172-177
-
-
Kielstein, J.T.1
Impraim, B.2
Simmel, S.3
Bode-Boger, S.M.4
Tsikas, D.5
Frolich, J.C.6
Hoeper, M.M.7
Haller, H.8
Fliser, D.9
-
21
-
-
0041733065
-
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
-
Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P: Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455-1459, 2003
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1455-1459
-
-
Achan, V.1
Broadhead, M.2
Malaki, M.3
Whitley, G.4
Leiper, J.5
MacAllister, R.6
Vallance, P.7
-
22
-
-
0023200487
-
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
-
Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057-1058, 1987
-
(1987)
Lancet
, vol.2
, pp. 1057-1058
-
-
Radomski, M.W.1
Palmer, R.M.2
Moncada, S.3
-
23
-
-
0030033842
-
Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells
-
Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230, 1996
-
(1996)
Circ Res
, vol.78
, pp. 225-230
-
-
Sarkar, R.1
Meinberg, E.G.2
Stanley, J.C.3
Gordon, D.4
Webb, R.C.5
-
24
-
-
0036526328
-
Hemodialysis vascular access dysfunction from basic biology to clinical intervention
-
Roy-Chaudhury P, Kelly BS, Narayana A, Desai P, Melham M, Munda R, Duncan H, Heffelfinger SC: Hemodialysis vascular access dysfunction from basic biology to clinical intervention. Adv Ren Replace Ther 9: 74-84, 2002
-
(2002)
Adv Ren Replace Ther
, vol.9
, pp. 74-84
-
-
Roy-Chaudhury, P.1
Kelly, B.S.2
Narayana, A.3
Desai, P.4
Melham, M.5
Munda, R.6
Duncan, H.7
Heffelfinger, S.C.8
-
25
-
-
0036433492
-
Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis
-
Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P: Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 62: 2272-2280, 2002
-
(2002)
Kidney Int
, vol.62
, pp. 2272-2280
-
-
Kelly, B.S.1
Heffelfinger, S.C.2
Whiting, J.F.3
Miller, M.A.4
Reaves, A.5
Armstrong, J.6
Narayana, A.7
Roy-Chaudhury, P.8
-
26
-
-
0034672521
-
Nitric oxide and postangioplasty restenosis: Pathological correlates and therapeutic potential
-
Janero DR, Ewing JF: Nitric oxide and postangioplasty restenosis: Pathological correlates and therapeutic potential. Free Radic Biol Med 29: 1199-1221, 2000
-
(2000)
Free Radic Biol Med
, vol.29
, pp. 1199-1221
-
-
Janero, D.R.1
Ewing, J.F.2
-
27
-
-
0033101853
-
Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: Effects on neointimal hyperplasia and vascular remodeling
-
Le Tourneau T, Van Belle E, Corseaux D, Vallet B, Lebuffe G, Dupuis B, Lablanch JM, McFadden E, Bauters C, Bertrand ME: Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: Effects on neointimal hyperplasia and vascular remodeling. J Am Coll Cardiol 33: 876-882, 1999
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 876-882
-
-
Le Tourneau, T.1
Van Belle, E.2
Corseaux, D.3
Vallet, B.4
Lebuffe, G.5
Dupuis, B.6
Lablanch, J.M.7
McFadden, E.8
Bauters, C.9
Bertrand, M.E.10
-
28
-
-
0032492738
-
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
-
Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D: Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97: 1274-1281, 1998
-
(1998)
Circulation
, vol.97
, pp. 1274-1281
-
-
Janssens, S.1
Flaherty, D.2
Nong, Z.3
Varenne, O.4
van Pelt, N.5
Haustermans, C.6
Zoldhelyi, P.7
Gerard, R.8
Collen, D.9
-
29
-
-
0032167652
-
Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs
-
Varenne O, Pislaru S, Gillijns H, van Pelt N, Gerard R, Zoldhelyi P, Van De Werf F, Collen D, Janssens SP: Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98: 919-926, 1998
-
(1998)
Circulation
, vol.98
, pp. 919-926
-
-
Varenne, O.1
Pislaru, S.2
Gillijns, H.3
van Pelt, N.4
Gerard, R.5
Zoldhelyi, P.6
Van De Werf, F.7
Collen, D.8
Janssens, S.P.9
-
30
-
-
0142209281
-
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
-
Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC: Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24: 1912-1919, 2003
-
(2003)
Eur Heart J
, vol.24
, pp. 1912-1919
-
-
Lu, T.M.1
Ding, Y.A.2
Lin, S.J.3
Lee, W.S.4
Tai, H.C.5
-
31
-
-
0037083145
-
Effect of local delivery of L-arginine on in-stent restenosis in humans
-
Suzuki T, Hayase M, Hibi K, Hosokawa H, Yokoya K, Fitzgerald PJ, Yock PG, Cooke JP, Suzuki T, Yeung AC: Effect of local delivery of L-arginine on in-stent restenosis in humans. Am J Cardiol 89: 363-367, 2002
-
(2002)
Am J Cardiol
, vol.89
, pp. 363-367
-
-
Suzuki, T.1
Hayase, M.2
Hibi, K.3
Hosokawa, H.4
Yokoya, K.5
Fitzgerald, P.J.6
Yock, P.G.7
Cooke, J.P.8
Suzuki, T.9
Yeung, A.C.10
-
32
-
-
4644326910
-
Inflammation and restenosis after percutaneous coronary interventions
-
Toutouzas K, Colombo A, Stefanadis C: Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25: 1679-1687, 2004
-
(2004)
Eur Heart J
, vol.25
, pp. 1679-1687
-
-
Toutouzas, K.1
Colombo, A.2
Stefanadis, C.3
-
33
-
-
0037164104
-
Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
-
Homocysteine Studies Collaboration
-
Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288: 2015-2022, 2002
-
(2002)
JAMA
, vol.288
, pp. 2015-2022
-
-
-
34
-
-
13444251648
-
Homocysteine in uraemia: A puzzling and conflicting story
-
Suliman ME, Barany P, Kalantar-Zadeh K, Lindholm B, Stenvinkel P: Homocysteine in uraemia: A puzzling and conflicting story. Nephrol Dial Transplant 20: 16-21, 2005
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 16-21
-
-
Suliman, M.E.1
Barany, P.2
Kalantar-Zadeh, K.3
Lindholm, B.4
Stenvinkel, P.5
-
35
-
-
3342880904
-
Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia
-
Paiva H, Lehtimaki T, Laakso J, Ruokonen I, Tervonen R, Metso S, Nikkila M, Wuolijoki E, Laaksonen R: Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia. Metabolism 53: 1072-1075, 2004
-
(2004)
Metabolism
, vol.53
, pp. 1072-1075
-
-
Paiva, H.1
Lehtimaki, T.2
Laakso, J.3
Ruokonen, I.4
Tervonen, R.5
Metso, S.6
Nikkila, M.7
Wuolijoki, E.8
Laaksonen, R.9
-
36
-
-
0033812927
-
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a highfat meal in patients with type 2 diabetes
-
Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Rammasamy R, Berglund L, Ginsberg SN, Homma S, Cannon PJ: Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a highfat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20: 2039-2044, 2000
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 2039-2044
-
-
Fard, A.1
Tuck, C.H.2
Donis, J.A.3
Sciacca, R.4
Di Tullio, M.R.5
Wu, H.D.6
Bryant, T.A.7
Chen, N.T.8
Torres-Tamayo, M.9
Rammasamy, R.10
Berglund, L.11
Ginsberg, S.N.12
Homma, S.13
Cannon, P.J.14
-
37
-
-
0344791653
-
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
-
Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 594-600
-
-
Kielstein, J.T.1
Boger, R.H.2
Bode-Boger, S.M.3
Schaffer, J.4
Barbey, M.5
Koch, K.M.6
Frolich, J.C.7
-
38
-
-
33750973371
-
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients
-
Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A: Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis 48: 797-805, 2006
-
(2006)
Am J Kidney Dis
, vol.48
, pp. 797-805
-
-
Kumagai, H.1
Sakurai, M.2
Takita, T.3
Maruyama, Y.4
Uno, S.5
Ikegaya, N.6
Kato, A.7
Hishida, A.8
-
39
-
-
0036828019
-
Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X
-
Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS: Long-term angiotensin- converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90: 974-982, 2002
-
(2002)
Am J Cardiol
, vol.90
, pp. 974-982
-
-
Chen, J.W.1
Hsu, N.W.2
Wu, T.C.3
Lin, S.J.4
Chang, M.S.5
-
40
-
-
0033594888
-
Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase
-
Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99: 3092-3095, 1999
-
(1999)
Circulation
, vol.99
, pp. 3092-3095
-
-
Ito, A.1
Tsao, P.S.2
Adimoolam, S.3
Kimoto, M.4
Ogawa, T.5
Cooke, J.P.6
-
41
-
-
0029360750
-
Induction of NG-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO synthases?
-
Bogle RG, MacAllister RJ, Whitley GS, Vallance P: Induction of NG-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO synthases? Am J Physiol 269: C750-C756, 1995
-
(1995)
Am J Physiol
, vol.269
-
-
Bogle, R.G.1
MacAllister, R.J.2
Whitley, G.S.3
Vallance, P.4
-
42
-
-
34447525317
-
Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency
-
Sajgure A, Choudhury A, Ahmed Z, Choudhury D: Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency. Nephrol Dial Transplant 22: 1390-1398, 2007
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 1390-1398
-
-
Sajgure, A.1
Choudhury, A.2
Ahmed, Z.3
Choudhury, D.4
-
43
-
-
0027462812
-
Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
-
Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM: Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 39: 263-271, 1993
-
(1993)
Clin Chem
, vol.39
, pp. 263-271
-
-
Fiskerstrand, T.1
Refsum, H.2
Kvalheim, G.3
Ueland, P.M.4
-
44
-
-
11244354179
-
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay
-
Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Böger RH: Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42: 1377-1383, 2004
-
(2004)
Clin Chem Lab Med
, vol.42
, pp. 1377-1383
-
-
Schulze, F.1
Wesemann, R.2
Schwedhelm, E.3
Sydow, K.4
Albsmeier, J.5
Cooke, J.P.6
Böger, R.H.7
-
45
-
-
0032785091
-
Reporting standards for percutaneous interventions in dialysis access. Technology Assessment Committee
-
Gray RJ, Sacks D, Martin LG, Trerotola SO: Reporting standards for percutaneous interventions in dialysis access. Technology Assessment Committee. J Vasc Interv Radiol 10: 1405-1415, 1999
-
(1999)
J Vasc Interv Radiol
, vol.10
, pp. 1405-1415
-
-
Gray, R.J.1
Sacks, D.2
Martin, L.G.3
Trerotola, S.O.4
|